TY  - RPRT
TI  - Prioritization prostate cancer to immune checkpoint therapy by ranking tumors along IFN-γ axis and identification of immune resistance mechanisms
AU  - Reva, B.
AU  - Omelchenko, T.
AU  - Calinawan, A. P.
AU  - Nair, S.
AU  - Schadt, E.
AU  - Tewari, A.
PY  - 2020
DO  - 10.1101/2020.10.19.345629
UR  - https://www.biorxiv.org/content/10.1101/2020.10.19.345629v1
ID  - 10.1101/2020.10.19.345629
ER  -